With the emergence and long-term Impact of COVID-19, Global Solid Tumor Testing Market to reach USD 43.76 Billion by 2030
Bizwit Research & Consulting LLP’s recent analysis on Global Solid Tumor Testing Market points towards a potential rise to USD 43.76 Billion by 2030. A solid tumour is characterized as an uncontrolled cell development that does not include fluids or cysts. For the early-stage diagnosis of tumors, solid tumour testing is used. Despite significant research into the biology of solid tumors and the development of tests for the detection of solid tumors, they remain one of the main causes of death. Genetic and conventional testing are the two methods used to diagnose solid tumors. The Solid Tumor Testing market is expanding because of factors such as the rising prevalence of cancer and new product approvals in ovarian, pancreatic, and prostate cancers.
Geographically, the global Solid Tumor Testing market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in terms of revenue due to the prevalence of important market players and the increased frequency of diseases in the area. On the other hand, the Asia Pacific region is projected to have the highest CAGR during the forecast period due to a variety of factors, such as an increase in the target and geriatric populations, an increase in the number of product development collaborations, the geographic expansion of major players, and active participation by nonprofit and governmental organisations in the market.
The global Solid Tumor Testing market is highly competitive owing to the presence of several key players such as Qiagen Quest Diagnostics Inc Abbott Laboratories Agilent Technologies Inc. Biocare Medical LLC F. Hoffmann-La Roche AG Illumina, Inc. MedGenome Labs Private Ltd Myriad Genetics, Inc. Thermo Fisher Scientific, Inc, and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Global Solid Tumor Testing Market Size study & Forecast, by Type (Genetic Testing, Conventional Testing), by Application (Prostate, Breast, Colorectal, Endometrial, Lung, Melanoma, Brain, Others), by End Use (Hospitals, Pharmaceutical and biotechnology companies, Contract research organizations, Academic research institutions) and Regional Analysis, 2023-2030
Key findings of the study suggest:
- Global Solid Tumor Testing Market is anticipated to grow with a healthy growth rate of more than 7.0% over the forecast period 2023-2030.
- In the Type segment, Genetic Testing emerged out as the leading market segment in 2022.
- North America is anticipated to drive regional growth owing to the prevalence of important market players and the increased frequency of diseases in the area.
- Asia Pacific is expected to grow at higher rate followed by Europe during 2023-2030.
Bizwit Research & Consulting has considered following segments for the study:
- Genetic Testing
- Conventional Testing
By End Use:
- Pharmaceutical and biotechnology companies
- Contract research organizations
- Academic research institutions
- North America
- Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: firstname.lastname@example.org
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Global Business Development
Phone: +1 209 498-3066